* Corresponding Author
Impact of irrational antibiotic therapy to hospital cost of care of pneumonia in patients in Dr. Sardjito Hospital
https://doi.org/10.22146/acta%20interna.5002 Edi Sutrisno(1*)
(1)
(*) Corresponding Author
Abstract
Background: The mortality rate from pneumonia remains very high, reaching 15% in the United States while in
Indonesia pneumonia is the second leading cause of death. Antibiotics improve outcomes in those with bacterial
pneumonia. Irrational antibiotic therapy impacts to bacteria resistance, potentially increasing side effects of drugs,
prolonged patient’s length of stay and higher total hospital costs.
Aim: This study aimed to improve the service quality by calculating the percentage of irrational antibiotic therapy
based on Gyssens workfl ow and the additional total of consumables antibiotics costs.
Methods: The study design was retrospective, including 57 pneumonia inpatients in internal medicine department
wards in Dr. Sardjito Hospital, from November 2011 to January 2012. Statistical analyses were conducted by
using Mann-Whitney U test.
Results: From 57 pneumonia inpatients, irrational antibiotic therapy reached 68,4% (39 of 57 patients).
Azithromycin was misused and overused antibiotic. Total excess cost of daily antibiotic were Rp 294,000.00
and consumables antibiotics were Rp 215,000.00
Conclusion: Irrational antibiotic therapy in pneumonia is associated with and an overall impacts on healthcare
costs.
Keywords: irrational antibiotic therapy, health-care cost, and customer satisfaction.
Full Text:
PDFReferences
REFERENCES
Brooks, G. F., Butel, J. S., Morse, S. A. (2008).
Mikrobiologi Kedokteran, Penerbit Buku Kedokteran
EGC, Jakarta.
Brunton, L., Lazo, J. S., Parker, K. L., Buxton, Iain
L. O., dan Blumenthal, D. K., (2006). Goodman
and gilman the pharmacological basis of
therapeutics,edisi 11, the McGraw-Hill Companies,
Inc., USA, chapter 42.
Budiharto, M., Suryati, T., Tarigan, I.(2007) Anaisis
biaya obat untuk penyakit kebidanan rawat inap
rumah sakit ( sebelum dan selama krisis). Buletin.
Penelitian system kesehatan. Vol 10 3 Juli 2007:
-222.
Burgess, D. S. (2008). Antimicrobial Regimen
Selection, in JosephT, D., Robert L, T., Gary C,
Y., Gary R, M., Barbara G, W., and L, M. P. (Eds),
Pharmacotherapy: A Pathophysiologic Approach,
McGraw-Hill Company Inc., pp. 1731-1738.
Chamber, F.H.(2002). Antimicrobial Agents in
JG. Hardman, LE. Limbird, AG.Gilman, (Eds),
Table 3. Count of Rationality Antibiotic
Rationality Count Percentage (%)
Rasional (R) 18 31,6%
Irasional (I) 39 68,4%
Table 4. Cost of Antibiotics and Consumables Analysis
N Minimum Maximum Median ± SD P
Cost of AB ( IDR) 57 10.050,00 12.935.096,00 160.445,00 ± 32,00 0,354
Cost of HP (IDR) 57 220.633,80 9.531.362,00 824.060,00 ± 33,89 0,131
Cost of AB/days (IDR) 57 5.025,00 1.847.870,86 5.590,71 ± 36,56 0,328
Cost of HP/days (IDR) 57 35.095,00 943.638,25 31.094,50 ± 32,17 0,020
Edi Sutrisno, Riska Humardewayanti, Putut Bayupurnama
Pharmacological Basis of Therapeutics, 10th edition,
McGraw-Hill, New York, pp. 1143-1169
Cusini, A., Rampini, S, K., Bansal, V., Ledergerber,
B., Kuster, S, P., Ruef, C., Weber, R. (2010).
Different Patterns of Inappropriate Antimicrobial
Use in Surgical and Medical Units at a Tertiary Care
Hospital in Switzerland: A Prevalence Survey. PLoS
ONE 5(11): e14011
Goodman and Gilman. (2006). The Pharmacological
Basis of Therapeutics, 11th Ed, The McGraw-Hill
Companies, USA.
Goodman and Gilman. (2008). Manual of
Pharmacology and Therapeutics,The McGraw-
Hill Companies, USA, pp.707-715.
Greenwood, D., Finch, R., Davey, P., Wilcox,
M.(2007). Antimicrobial Chemotherapy 5th Edition,
Oxford University Press, New York, pp.183 – 193
Guidelines for the Management of adults with
Hospital-acquired, Ventilator-associated, and
Healthcare-associated Pneumonia. (2004).
American Thoracic Society Documents.
Gyssens, I. C. (2005). Audits for Monitoring the
Quality ofAntimicrobial Prescriptions, In: Gould, I
.M., Van der Meer, J .W .M.,eds. Antibiotic Policies:
Theory and Practice, Kluwer Academic/Plenum
Publishers, New York, chapter 12.
Harini, D., Sadjimin, T., Damanik, M. P.(2006). Cost
Effectiveness Kotrimoksazol dan Ampisilin pada
Penderita Infeksi Saluran Kemih.Tesis. Program Pasca
Sarjana Universitas Gajah Mada. Yogyakarta.
Holloway.(2004). Rational Use of Medicine. The
world medicines situation. WHO report.
Juwono, R., dan Prayitno, A., 2003, Terapi Antibiotik,
In: Aslam, dkk.,Farmasi Klinis, Penerbit PT Elex Media
KomputindoGramedia, Jakarta, pp.321-333.
Kuntaman, Paraton, H., 2011, Strategi pengendalian
resistensi antimikroba dalam Workshop 2011: Peran
aktif farmasis pada pengelolaan kasus infeksi dan
pengendalian penggunaan antibiotik, Tim PPRA,
HISFARSI dan IAI Jawa Timur, pp.12.
Mandell, L. A., Wunderink, R. G., Anzueto, A.,
Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell,
S. F., File, T. M., Musher, D. M., Niederman, M.
S., Torres, A., Whitney, C. G., 2007, Infectious
Diseases Society of America/American Thoracic
Society Consensus Guidelines on the management
of Community-Acquired Pneumonia in Adults.
Linical Infectious Diseases, 44: 27-72.
Munaf, S., Nattadiputra, S., 2009, Kumpulan Kuliah
Farmakologi, Penerbit Buku Kedokteran EGC,
Jakarta, pp. 3-15, pp. 599-607.
Nasronudin, 2011, Penyakit Infeksi di Indonesia
Solusi Kini dan Mendatang. Pusat Penerbitan dan
Percetakan Unair. Surabaya.
Nelwan, R.H.H.,2006, Pemakaian Antimikroba
Secara R,asional di Klinik dalam buku Ajar Ilmu
penyakit Dalam Jilid III, edisi IV, Pusat Penerbitan
Departemen Ilmu Penyakit Dalam FKUI Jakarta,
pp.1722-1723
Ningrum, I.,2008, Evaluasi Penggunaan Antibiotik
Berdasarkan Kriteria Gyssens Pasien Rawat Inap
Kelas III di Bagian Ilmu Penyakit Dalam RSUP
Dr.Kariadi Periode Agustus – Desember 2008, Skripsi,
Fakultas Kedokteran Universitas Diponegoro, p.1.
Puspita, 2011, Evaluasi rasionaitas penggunaan
antibiotik untuk terapi infeksi pada pasien rawat
inap di Bangsal Penyakit Dalam RSUP Dr. Sardjito.
Tesis. Program Pasca Sarjana Universitas Gajah
Mada. Yogyakarta.
Puteri, T. D., 2012, Analisis biaya penggunaan
antibiotikpada pasien pneumonia di instalasi rawat
inap anak RSUP Dr. M. Djamil Padang.
Raveh, D., Muallem-Zilcha, E., Greenberg, A.,
Wiener-Well, Y. Schlesinger, Y., Yinnon, A.M.,
, Prospective drug utilization evaluation of
three broad spectrum antimicrobials : cefepime,
piperacillin-tazobactam and meropenem, Q J Med,
: 397–406
Russell D.A., 2004, Hugo and Russel’s
Pharmaceutical Microbiology 7th edition, edited
by Stephen Denyer, Norman A. Hodges, Sean P.
Gorman, Blackwell, United Kingdom
Sastramihardja, H. S., 1997, Penggunaan Antibiotika
yang Rasional, editor, Muchtaruddin Mansyur, IDI,
Jakarta, pp. 1-4.
Shah, B. A., Ahmed, W., Dhobi, G. N., Shah,
N. N., Khursheed, S. Q., Haq, I., 2010, Validity
of Pneumonia Severity Index and CURB-65
Severity Scoring Systems in Community Acquired
Pneumonia in an Indian Setting. Indian J Chest Dis
Allied Sci, 52: 9-17.
Smyth, E., 2009, Guidelines for antimicrobials
stewardship in Hospital in Irland, SARI Hospital
antimicrobials working group, Health Protection
Surveillance Centre, Dublin
Soedarsono, 2010, Pneumonia in Wibisono, M.J.,
Winariani, Hariadi, S., Buku Ajar Penyakit Paru.
Departemen Ilmu Penyakit Paru FK- UNAIR. Edisi
; 149-79.
Tünger, O., Dinç G., Ozbakkaloglu, B., Atman, U,
C., Algun, U., 2000, Evaluation of rational antibiotic
use, International Journal of Antimicrobial Agents,
: 131–135
White, R. L., 2005, How Do measurements of Antibiotic
Consumtion Relate to Antibiotic Resistance?, In
Antibiotic Policy : Theory and Practice, Edited by
Gould and van de Meer, Kluwer academic/Plenum
Publisher, New York, pp.75 – 98
WHO, 2003, Introduction to Drug Utilization
Research/WHO Collaborating Centre for Drug
Statistics and Methodology, WHO Collaborating
Centre for Drug Statistics and Methodology, WHO
Collaborating Centre for Drug Utilization Research
and Clinical Pharmacological Service, WHO, Oslo,
Norway.
WHO, 2004, Practical guidelines for Infection
control in Health Care Facilities, WHO Regional
Offi ce for South East Asia, New Delhi.
DOI: https://doi.org/10.22146/acta%20interna.5002
Article Metrics
Abstract views : 1083
| 
views : 1248
Refbacks
- There are currently no refbacks.
Copyright (c) 2013 Acta Interna The Journal of Internal Medicine
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Acta Interna The Journal of Internal Medicine Indexed by:
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.